These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9336832)

  • 1. Unusual conformation of nicotinamide adenine dinucleotide (NAD) bound to diphtheria toxin: a comparison with NAD bound to the oxidoreductase enzymes.
    Bell CE; Yeates TO; Eisenberg D
    Protein Sci; 1997 Oct; 6(10):2084-96. PubMed ID: 9336832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Adv Exp Med Biol; 1997; 419():35-43. PubMed ID: 9193634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking distinct conformations of nicotinamide adenine dinucleotide with protein fold/function.
    Kuppuraj G; Sargsyan K; Hua YH; Merrill AR; Lim C
    J Phys Chem B; 2011 Jun; 115(24):7932-9. PubMed ID: 21612228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual folded conformation of nicotinamide adenine dinucleotide bound to flavin reductase P.
    Tanner JJ; Tu SC; Barbour LJ; Barnes CL; Krause KL
    Protein Sci; 1999 Sep; 8(9):1725-32. PubMed ID: 10493573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
    Blanke SR; Huang K; Wilson BA; Papini E; Covacci A; Collier RJ
    Biochemistry; 1994 May; 33(17):5155-61. PubMed ID: 8172890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
    Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
    J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active-site mutations of diphtheria toxin: role of tyrosine-65 in NAD binding and ADP-ribosylation.
    Blanke SR; Huang K; Collier RJ
    Biochemistry; 1994 Dec; 33(51):15494-500. PubMed ID: 7803411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of nucleotide-free diphtheria toxin.
    Bell CE; Eisenberg D
    Biochemistry; 1997 Jan; 36(3):481-8. PubMed ID: 9012663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of the short-chain flavin reductase HpaC from Sulfolobus tokodaii strain 7 in its three states: NAD(P)(+)(-)free, NAD(+)(-)bound, and NADP(+)(-)bound.
    Okai M; Kudo N; Lee WC; Kamo M; Nagata K; Tanokura M
    Biochemistry; 2006 Apr; 45(16):5103-10. PubMed ID: 16618099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of diphtheria toxin fragment A with 8-azidoadenosyl nicotinamide adenine dinucleotide.
    Lodaya R; Blanke SR; Collier RJ; Slama JT
    Biochemistry; 1999 Oct; 38(42):13877-86. PubMed ID: 10529233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
    Ruf A; de Murcia G; Schulz GE
    Biochemistry; 1998 Mar; 37(11):3893-900. PubMed ID: 9521710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADP-dependent enzymes. II: Evolution of the mono- and dinucleotide binding domains.
    Carugo O; Argos P
    Proteins; 1997 May; 28(1):29-40. PubMed ID: 9144788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphtheria toxin catalyzed hydrolysis of NAD(+): molecular dynamics study of enzyme-bound substrate, transition state, and inhibitor.
    Kahn K; Bruice TC
    J Am Chem Soc; 2001 Dec; 123(48):11960-9. PubMed ID: 11724604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformations of nicotinamide adenine dinucleotide (NAD(+)) in various environments.
    Smith PE; Tanner JJ
    J Mol Recognit; 2000; 13(1):27-34. PubMed ID: 10679894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of diphtheria toxin with adenylyl-(3',5')-uridine 3'-monophosphate. II. The NAD-binding site and determinants of dinucleotide affinity.
    Collins CM; Collier RJ
    J Biol Chem; 1984 Dec; 259(24):15159-62. PubMed ID: 6511789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity in the binding of NAD(P)+ analogues to NAD- and NADP-dependent pig heart isocitrate dehydrogenases. A nuclear magnetic resonance study.
    Ehrlich RS; Colman RF
    Biochemistry; 1992 Dec; 31(49):12524-31. PubMed ID: 1463739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.